胸主动脉腔内修复术后呼吸系统不良事件的相关因素与结局
基于血管质量倡议(VQI)2010至2023年10,708例非创伤性胸主动脉腔内修复(TEVAR)患者,术后呼吸系统不良事件(RAE)发生率为8.3%。男性、肥胖、肾功能不全、贫血、慢性阻塞性肺疾病家庭氧疗、急性主动脉夹层、破裂表现、同日胸部分支治疗及术中输血与RAE相关,发生RAE者5年死亡风险升高(aHR 1.8)。
要点
- TEVAR术后任何RAE发生率为8.3%,其中单纯肺炎2.1%、单纯再插管4.8%、两者兼有1.4%。
- 发生RAE者30天死亡率27% vs 无RAE者4%,5年死亡率46% vs 20%(P均<.001)。
- 校正术前及术后变量后,任何RAE与5年死亡风险升高相关(aHR 1.8;95%CI 1.6-2.1;P<.001)。
核心结论
- TEVAR术后呼吸系统不良事件常见,在肥胖、肾功能不全、贫血、COPD家庭氧疗、急性主动脉夹层、破裂表现、同日胸部分支治疗及术中输血的患者中更易发生。
- 发生术后RAE与5年死亡风险约增加两倍相关,且独立于其他术后非呼吸系统并发症。
- 作者认为在评估TEVAR风险与获益时考虑这些因素并实施个体化术后护理,可能改善临床结局。
研究设计与样本
- 回顾性队列研究,数据来自血管质量倡议(Vascular Quality Initiative),纳入2010至2023年因非创伤性病变行TEVAR且限于0至5区的患者,共10,708例。
- 按术后呼吸并发症状态分层:无、仅肺炎、仅再插管、两者兼有。
- 采用多变量修正Poisson回归分析术前和术中变量与术后RAE的独立关联。
- 采用Kaplan-Meier分析和Cox比例风险回归模型评估术后RAE与5年生存的关联,校正术前变量及其他非呼吸系统术后并发症。
主要发现
- 10,708例患者中,8.3%发生任何RAE(仅肺炎2.1%,仅再插管4.8%,两者兼有1.4%)。
- 发生任何RAE者更常表现为主动脉夹层(46% vs 35%;P<.001)和有症状(58% vs 48%;P<.001)。
- 与术后RAE独立相关的因素包括:男性(aRR 1.19;95%CI 1.01-1.41;P=.037)、肥胖(aRR 1.31;95%CI 1.07-1.61;P=.009)、病态肥胖(aRR 1.68;95%CI 1.20-2.32;P=.002)、肾功能不全(eGFR 30-45:aRR 1.45;95%CI 1.15-1.82;P=.002;eGFR<30/血液透析:aRR 1.7;95%CI 1.37-2.11;P<.001)、贫血(aRR 1.31;95%CI 1.09-1.58;P=.003)、主动脉直径>65 mm(aRR 1.54;95%CI 1.25-1.89;P<.001)、主动脉弓近端病变(aRR 1.23;95%CI 1.03-1.48;P=.025)或升主动脉近端病变(aRR 1.61;95%CI 1.19-2.14;P=.002)、急性主动脉夹层(aRR 2.13;95%CI 1.72-2.63;P<.001)、破裂表现(aRR 3.07;95%CI 2.43-3.87;P<.001)、同日外科胸部分支治疗(aRR 1.51;95%CI 1.25-1.82;P<.001)、COPD家庭氧疗(aRR 1.58;95%CI 1.08-2.25;P=.014)、有限自我照护或卧床状态(aRR 2.12;95%CI 1.45-3.03;P<.001)及术中输血(aRR 1.88;95%CI 1.47-2.40;P<.001)。
- 发生术后RAE者30天死亡率高于无呼吸并发症者(27% vs 4%;P<.001),5年死亡率亦更高(46% vs 20%;P<.001)。
- 校正术前和术后变量后,发生任何术后RAE者5年死亡率更高(aHR 1.8;95%CI 1.6-2.1;P<.001);仅肺炎(aHR 1.4;95%CI 1.0-1.8;P=.046)、仅再插管(aHR 2.2;95%CI 1.8-2.6;P<.001)及两者兼有(aHR 1.5;95%CI 1.1-2.0;P=.008)均与5年死亡率升高相关。
临床怎么用
- 作者认为在评估TEVAR风险与获益时考虑上述因素并实施个体化术后护理,可能改善临床结局。
- 原文未据此给出其他推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Respiratory adverse events (RAEs) after thoracic endovascular aortic repair (TEVAR) remain poorly characterized owing to the lack of comprehensive studies that identify individuals prone to these complications. This study aims to determine the incidence, factors associated with, and outcomes of RAEs after TEVAR. METHODS: We identified patients in the Vascular Quality Initiative undergoing TEVAR isolated to zones 0 to 5 from 2010 to 2023 for nontraumatic pathologies. After determining the incidence of postoperative RAEs, we assessed baseline characteristics, pathology, procedural details, and postoperative complications stratified by respiratory complication status: none, pneumonia only, reintubation only, or both. We then examined preoperative and intraoperative variables independently associated with the development of postoperative RAEs using multivariable modified Poisson regression. Kaplan-Meier analysis and Cox proportional hazards regression models were used to determine associations between postoperative RAEs and 5-year survival adjusting for preoperative variables and other nonrespiratory postoperative complications in a separate model. RESULTS: Of 10,708 patients, 8.3% had any RAE (pneumonia only, 2.1%; reintubation only, 4.8%; both, 1.4%). Patients with any RAE were more likely to present with aortic dissection (any respiratory complication, 46% vs no respiratory complication, 35%; P < .001), and be symptomatic (58% vs 48%; P < .001). Developing RAEs after TEVAR was associated with male sex (adjusted relative risk [aRR], 1.19; 95% confidence interval [CI], 1.01-1.41; P = .037), obesity (aRR, 1.31; 95% CI, 1.07-1.61; P = .009), morbid obesity (aRR, 1.68; 95% CI, 1.20-2.32; P = .002), renal dysfunction (aRR, estimated glomerular filtration rate 30-45, 1.45; 95% CI, 1.15-1.82; P = .002; estimated glomerular filtration rate <30/hemodialysis, 1.7; 95% CI, 1.37-2.11; P < .001), anemia (aRR, 1.31; 95% CI, 1.09-1.58; P = .003), aortic diameter >65 mm (aRR, 1.54; 95% CI, 1.25-1.89; P < .001), proximal disease in the aortic arch (aRR, 1.23; 95% CI, 1.03-1.48; P = .025) or ascending aorta (aRR, 1.61; 95% CI, 1.19-2.14; P = .002), acute aortic dissection (aRR, 2.13; 95% CI, 1.72-2.63; P < .001), ruptured presentation (aRR, 3.07; 95% CI, 2.43-3.87; P < .001), same-day surgical thoracic branch treatment (aRR, 1.51; 95% CI, 1.25-1.82; P < .001), chronic obstructive pulmonary disease on home oxygen (aRR, 1.58; 95% CI, 1.08-2.25; P = .014), limited self-care or bed-bound status (aRR, 2.12; 95% CI, 1.45-3.03; P < .001), and intraoperative transfusion (aRR, 1.88; 95% CI, 1.47-2.40; P < .001). Patients who developed postoperative RAEs had higher 30-day mortality (27% vs 4%; P < .001) and 5-year mortality than patients without respiratory complications (46% vs 20%; P < .001). After adjusting for preoperative and postoperative variables, the 5-year mortality was higher in patients who developed any postoperative RAE (adjusted hazard ratio [aHR], 1.8; 95% CI, 1.6, 2.1; P < .001), postoperative pneumonia only (aHR, 1.4; 95% CI, 1.0, 1.8; P = .046), reintubation only (aHR, 2.2; 95% CI, 1.8, 2.6; P < .001) or both (aHR, 1.5; 95% CI, 1.1, 2.0; P = .008). CONCLUSIONS: RAEs after TEVAR are common, more likely to occur in male patients with obesity, renal dysfunction, anemia, chronic obstructive pulmonary disease on home oxygen, acute aortic dissection, ruptured presentation, same-day surgical thoracic branch treatment, who received intraoperative transfusion, and are associated with a two-fold increase in 5-year mortality regardless of the development of other postoperative complications. Considering these factors in assessing the risks and benefits of TEVAR procedures, along with implementing customized postoperative care, can potentially improve clinical outcomes.
引用
- Jabbour G, Mandigers TJ, Mantovani F, et al. Factors associated with and outcomes of respiratory adverse events following thoracic endovascular aortic repair. J Vasc Surg. 2024. PMID: 39237059. doi:10.1016/j.jvs.2024.08.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。